Gene · 4738
Papers3,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive modular analyses of scar subtypes illuminate underlying molecular mechanisms and potential therapeutic targets. | Int Wound J | 2024 | 37697692 | PubTator, text mining | PubMed |
| Neddylation-dependent LSD1 destabilization inhibits the stemness and chemoresistance of gastric cancer. | Int J Biol Macromol | 2024 | 37689288 | PubTator, text mining | PubMed |
| Design principles for cyclin K molecular glue degraders. | Nat Chem Biol | 2024 | 37679459 | PubTator, text mining | PubMed |
| The ubiquitin codes in cellular stress responses. | Protein Cell | 2024 | 37470788 | PubTator, text mining | PubMed |
| CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis. | bioRxiv | 2024 | 37398204 | PubTator, text mining | PubMed |
| OTUB1-mediated inhibition of ubiquitination: a growing list of effectors, multiplex mechanisms, and versatile functions. | Front Mol Biosci | 2023 | 38264570 | PubTator, text mining | PubMed |
| Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology. | Front Pharmacol | 2023 | 38235113 | PubTator, text mining | PubMed |
| Molecular Insight into Gastric Cancer Invasion-Current Status and Future Directions. | Cancers (Basel) | 2023 | 38201481 | PubTator, text mining | PubMed |
| Targeting the Ubiquitin-Proteasome System and Recent Advances in Cancer Therapy. | Cells | 2023 | 38201233 | PubTator, text mining | PubMed |
| Modulation of neural gene networks by estradiol in old rhesus macaque females. | bioRxiv | 2023 | 38187564 | PubTator, text mining | PubMed |
| Identification of Adenovirus E1B-55K Interaction Partners through a Common Binding Motif. | Viruses | 2023 | 38140597 | PubTator, text mining | PubMed |
| Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression. | Biology (Basel) | 2023 | 38132337 | PubTator, text mining | PubMed |
| A dicer-related helicase opposes the age-related pathology from SKN-1 activation in ASI neurons. | Proc Natl Acad Sci U S A | 2023 | 38113255 | PubTator, text mining | PubMed |
| MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting. | Nat Commun | 2023 | 38102140 | PubTator, text mining | PubMed |
| Parkin-mediated ubiquitination inhibits BAK apoptotic activity by blocking its canonical hydrophobic groove. | Commun Biol | 2023 | 38087033 | PubTator, text mining | PubMed |
| A novel microtubule inhibitor promotes tumor ferroptosis by attenuating SLC7A11/GPX4 signaling. | Cell Death Discov | 2023 | 38086802 | PubTator, text mining | PubMed |
| Advance in Targeted Cancer Therapy and Mechanisms of Resistance. | Int J Mol Sci | 2023 | 38068907 | PubTator, text mining | PubMed |
| GARP and EARP are required for efficient BoHV-1 replication as identified by a genome wide CRISPR knockout screen. | PLoS Pathog | 2023 | 38055775 | PubTator, text mining | PubMed |
| Preserving genome integrity: The vital role of SUMO-targeted ubiquitin ligases. | Cell Insight | 2023 | 38047137 | PubTator, text mining | PubMed |
| Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy. | MedComm (2020) | 2023 | 38045829 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4738/papers?page=11